Position
Squarepoint Ops LLC in Acrivon Therapeutics, Inc.
Back to the book · All holders of ACRV
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$26.7K$2.41 → $1.39
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 26.2K | $63K | — | — | — | 0.0% |
| Q1 2026 | 27.5K | $38.2K | $1.39 | −$26.7K | $1.82K | 0.0% |